Protein Abundance of Clinically Relevant Multidrug Transporters along the Entire Length of the Human Intestine
Intestinal transporters are crucial determinants in the oral absorption of many drugs. We therefore studied the mRNA expression (N = 33) and absolute protein content (N = 10) of clinically relevant transporters in healthy epithelium of the duodenum, the proximal and distal jejunum and ileum, and the...
Saved in:
Published in | Molecular pharmaceutics Vol. 11; no. 10; pp. 3547 - 3555 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Chemical Society
06.10.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Intestinal transporters are crucial determinants in the oral absorption of many drugs. We therefore studied the mRNA expression (N = 33) and absolute protein content (N = 10) of clinically relevant transporters in healthy epithelium of the duodenum, the proximal and distal jejunum and ileum, and the ascending, transversal, descending, and sigmoidal colon of six organ donors (24–54 years). In the small intestine, the abundance of nearly all studied proteins ranged between 0.2 and 1.6 pmol/mg with the exception of those of OCT3 (<0.1 pmol/mg) and PEPT1 (2.6–4.9 pmol/mg) that accounted for ∼50% of all measured transporters. OATP1A2 was not detected in any intestinal segment. ABCB1, ABCG2, PEPT1, and ASBT were significantly more abundant in jejunum and ileum than in colon. In contrast to this, the level of expression of ABCC2, ABCC3, and OCT3 was found to be highest in colon. Site-dependent differences in the levels of gene and protein expression were observed for ABCB1 and ASBT. Significant correlations between mRNA and protein levels have been found for ABCG2, ASBT, OCT3, and PEPT1 in the small intestine. Our data provide further physiological pieces of the puzzle required to predict intestinal drug absorption in humans. |
---|---|
AbstractList | Intestinal transporters are crucial determinants in the oral absorption of many drugs. We therefore studied the mRNA expression (N = 33) and absolute protein content (N = 10) of clinically relevant transporters in healthy epithelium of the duodenum, the proximal and distal jejunum and ileum, and the ascending, transversal, descending, and sigmoidal colon of six organ donors (24-54 years). In the small intestine, the abundance of nearly all studied proteins ranged between 0.2 and 1.6 pmol/mg with the exception of those of OCT3 (<0.1 pmol/mg) and PEPT1 (2.6-4.9 pmol/mg) that accounted for ∼50% of all measured transporters. OATP1A2 was not detected in any intestinal segment. ABCB1, ABCG2, PEPT1, and ASBT were significantly more abundant in jejunum and ileum than in colon. In contrast to this, the level of expression of ABCC2, ABCC3, and OCT3 was found to be highest in colon. Site-dependent differences in the levels of gene and protein expression were observed for ABCB1 and ASBT. Significant correlations between mRNA and protein levels have been found for ABCG2, ASBT, OCT3, and PEPT1 in the small intestine. Our data provide further physiological pieces of the puzzle required to predict intestinal drug absorption in humans. Intestinal transporters are crucial determinants in the oral absorption of many drugs. We therefore studied the mRNA expression (N = 33) and absolute protein content (N = 10) of clinically relevant transporters in healthy epithelium of the duodenum, the proximal and distal jejunum and ileum, and the ascending, transversal, descending, and sigmoidal colon of six organ donors (24-54 years). In the small intestine, the abundance of nearly all studied proteins ranged between 0.2 and 1.6 pmol/mg with the exception of those of OCT3 (<0.1 pmol/mg) and PEPT1 (2.6-4.9 pmol/mg) that accounted for ∼50% of all measured transporters. OATP1A2 was not detected in any intestinal segment. ABCB1, ABCG2, PEPT1, and ASBT were significantly more abundant in jejunum and ileum than in colon. In contrast to this, the level of expression of ABCC2, ABCC3, and OCT3 was found to be highest in colon. Site-dependent differences in the levels of gene and protein expression were observed for ABCB1 and ASBT. Significant correlations between mRNA and protein levels have been found for ABCG2, ASBT, OCT3, and PEPT1 in the small intestine. Our data provide further physiological pieces of the puzzle required to predict intestinal drug absorption in humans.Intestinal transporters are crucial determinants in the oral absorption of many drugs. We therefore studied the mRNA expression (N = 33) and absolute protein content (N = 10) of clinically relevant transporters in healthy epithelium of the duodenum, the proximal and distal jejunum and ileum, and the ascending, transversal, descending, and sigmoidal colon of six organ donors (24-54 years). In the small intestine, the abundance of nearly all studied proteins ranged between 0.2 and 1.6 pmol/mg with the exception of those of OCT3 (<0.1 pmol/mg) and PEPT1 (2.6-4.9 pmol/mg) that accounted for ∼50% of all measured transporters. OATP1A2 was not detected in any intestinal segment. ABCB1, ABCG2, PEPT1, and ASBT were significantly more abundant in jejunum and ileum than in colon. In contrast to this, the level of expression of ABCC2, ABCC3, and OCT3 was found to be highest in colon. Site-dependent differences in the levels of gene and protein expression were observed for ABCB1 and ASBT. Significant correlations between mRNA and protein levels have been found for ABCG2, ASBT, OCT3, and PEPT1 in the small intestine. Our data provide further physiological pieces of the puzzle required to predict intestinal drug absorption in humans. |
Author | Prasad, Bhagwat Lai, Yurong Unadkat, Jashvant D Oswald, Stefan Lapczuk, Joanna Ostrowski, Marek Siegmund, Werner Drozdzik, Marek Penski, Jette Gröer, Christian |
AuthorAffiliation | Department of General and Transplantation Surgery Department of Pharmaceutics Department of Experimental and Clinical Pharmacology Department of Clinical Pharmacology Pfizer Global Research and Development University of Washington Department of Pharmacokinetics, Dynamics and Metabolism Pomeranian Medical University University Medicine Greifswald |
AuthorAffiliation_xml | – name: Department of General and Transplantation Surgery – name: Department of Pharmaceutics – name: Department of Pharmacokinetics, Dynamics and Metabolism – name: Pomeranian Medical University – name: University Medicine Greifswald – name: Department of Clinical Pharmacology – name: Pfizer Global Research and Development – name: Department of Experimental and Clinical Pharmacology – name: University of Washington |
Author_xml | – sequence: 1 givenname: Marek surname: Drozdzik fullname: Drozdzik, Marek – sequence: 2 givenname: Christian surname: Gröer fullname: Gröer, Christian – sequence: 3 givenname: Jette surname: Penski fullname: Penski, Jette – sequence: 4 givenname: Joanna surname: Lapczuk fullname: Lapczuk, Joanna – sequence: 5 givenname: Marek surname: Ostrowski fullname: Ostrowski, Marek – sequence: 6 givenname: Yurong surname: Lai fullname: Lai, Yurong – sequence: 7 givenname: Bhagwat surname: Prasad fullname: Prasad, Bhagwat – sequence: 8 givenname: Jashvant D surname: Unadkat fullname: Unadkat, Jashvant D – sequence: 9 givenname: Werner surname: Siegmund fullname: Siegmund, Werner – sequence: 10 givenname: Stefan surname: Oswald fullname: Oswald, Stefan email: stefan.oswald@uni-greifswald.de |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25158075$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtLJDEUhYM4-Ghd-AckG0EXPeZRj9RSGkeFHmYQXYdU6lYbSd20SUrofz_VtLoYXN3L5TvnwjnHZB8DAiFnnP3kTPDrYV0yJiXb7JEjXhZyrmQj9r92VRyS45ReGRNFKeQBORQlLxWryyOCf2PI4JDetCN2Bi3Q0NOFd-is8X5DH8HDu8FMf48-uy6OK_oUDaZ1iBliosYHXNH8AvQWs4tAl4Cr_LJ12R7vx8EgfcAMKTuEE_KjNz7B6ceckedft0-L-_nyz93D4mY5N1LxPJedBVnKqhJSiLJXdWFrITrVtIqrqoJWigIa6FRXS9H3krWKmboxyqpGgRJyRi53vusY3sbptx5csuC9QQhj0rxiDWuUmAKakfMPdGwH6PQ6usHEjf7MaAKud4CNIaUIvbYum-wC5mic15zpbQv6q4VJcfWf4tP0O_Zixxqb9GsYI065fMP9AxeRk1g |
CitedBy_id | crossref_primary_10_1080_10408398_2024_2387320 crossref_primary_10_1002_bdd_1931 crossref_primary_10_1016_j_ijpharm_2020_119678 crossref_primary_10_1016_j_pharmthera_2018_10_007 crossref_primary_10_1016_j_ejps_2019_04_013 crossref_primary_10_1016_j_ijpharm_2019_05_033 crossref_primary_10_1016_j_xphs_2019_04_019 crossref_primary_10_1124_dmd_119_087619 crossref_primary_10_1515_hsz_2016_0259 crossref_primary_10_3389_fnut_2024_1380010 crossref_primary_10_1124_dmd_115_064170 crossref_primary_10_1002_cpt_819 crossref_primary_10_1007_s11095_017_2157_8 crossref_primary_10_1016_j_ijpharm_2022_122282 crossref_primary_10_3390_ijms20194825 crossref_primary_10_1080_10717544_2018_1480675 crossref_primary_10_1016_j_bcp_2020_114127 crossref_primary_10_1124_jpet_114_219287 crossref_primary_10_1021_acs_molpharmaceut_7b00286 crossref_primary_10_1016_j_ejpb_2020_04_018 crossref_primary_10_1021_acs_molpharmaceut_9b00458 crossref_primary_10_1111_febs_15156 crossref_primary_10_1111_bcpt_13137 crossref_primary_10_3389_fphar_2021_692741 crossref_primary_10_1016_j_ajps_2019_10_004 crossref_primary_10_1016_j_ejps_2020_105280 crossref_primary_10_1016_j_jsbmb_2019_03_027 crossref_primary_10_1124_dmd_114_059873 crossref_primary_10_1016_j_etap_2014_10_007 crossref_primary_10_1021_acs_molpharmaceut_0c00903 crossref_primary_10_3389_fonc_2021_566539 crossref_primary_10_1007_s43440_020_00139_6 crossref_primary_10_1016_j_pharmr_2024_100023 crossref_primary_10_1016_j_clinre_2017_02_001 crossref_primary_10_1124_mol_117_111161 crossref_primary_10_1016_j_bcp_2020_114142 crossref_primary_10_1021_acs_jafc_0c06132 crossref_primary_10_1016_j_ejps_2018_02_014 crossref_primary_10_1016_j_ijpharm_2024_123962 crossref_primary_10_1002_cpph_22 crossref_primary_10_1055_a_1305_3936 crossref_primary_10_1016_j_ejps_2023_106452 crossref_primary_10_1016_j_ejps_2018_01_002 crossref_primary_10_1016_j_jep_2023_117057 crossref_primary_10_3389_fmolb_2021_763500 crossref_primary_10_1002_prp2_645 crossref_primary_10_3390_pharmaceutics12111064 crossref_primary_10_1002_bdd_2025 crossref_primary_10_1021_acs_molpharmaceut_9b00658 crossref_primary_10_1016_j_addr_2016_09_004 crossref_primary_10_1093_jac_dkv335 crossref_primary_10_1124_dmd_116_072397 crossref_primary_10_1248_bpb_b20_00342 crossref_primary_10_1016_j_bcp_2018_08_018 crossref_primary_10_3390_pharmaceutics12040296 crossref_primary_10_1016_j_ijbiomac_2023_124777 crossref_primary_10_1002_cpt_3497 crossref_primary_10_1016_j_tiv_2015_04_011 crossref_primary_10_1002_jcph_1421 crossref_primary_10_1021_acs_molpharmaceut_9b00897 crossref_primary_10_1208_s12248_017_0055_y crossref_primary_10_1002_jps_24447 crossref_primary_10_1016_j_ijpharm_2016_10_030 crossref_primary_10_1016_j_tiv_2016_12_002 crossref_primary_10_1124_dmd_124_001477 crossref_primary_10_1007_s11095_022_03397_6 crossref_primary_10_1111_bcp_13313 crossref_primary_10_1039_C6RA00673F crossref_primary_10_1124_dmd_119_086744 crossref_primary_10_1016_j_ejps_2018_07_057 crossref_primary_10_3390_pharmaceutics16010037 crossref_primary_10_3390_ijms21165737 crossref_primary_10_1007_s00210_018_1528_y crossref_primary_10_1124_dmd_119_090316 crossref_primary_10_1080_03602532_2024_2386597 crossref_primary_10_1007_s40268_020_00324_1 crossref_primary_10_1080_17425255_2020_1701653 crossref_primary_10_1124_dmd_118_082784 crossref_primary_10_3390_pharmaceutics15020542 crossref_primary_10_3389_fphys_2021_663170 crossref_primary_10_1124_dmd_117_078428 crossref_primary_10_1016_j_xphs_2017_04_001 crossref_primary_10_1016_j_drup_2016_06_005 crossref_primary_10_1016_j_xphs_2017_04_004 crossref_primary_10_1126_sciadv_abk3259 crossref_primary_10_1016_j_ejpb_2018_07_008 crossref_primary_10_3390_ijms20133257 crossref_primary_10_1002_cpt_1301 crossref_primary_10_1146_annurev_anchem_091719_024553 crossref_primary_10_1002_jps_24306 crossref_primary_10_1007_s13318_016_0361_2 crossref_primary_10_1124_dmd_115_068809 crossref_primary_10_1124_pr_118_015578 crossref_primary_10_1124_dmd_116_072231 crossref_primary_10_1517_17425255_2016_1125882 crossref_primary_10_1016_j_pharmthera_2018_12_009 crossref_primary_10_1021_acs_molpharmaceut_7b00563 crossref_primary_10_1021_acs_molpharmaceut_2c00950 crossref_primary_10_1007_s00360_016_1044_7 crossref_primary_10_1021_acs_molpharmaceut_2c01002 crossref_primary_10_1016_j_ejps_2018_04_021 crossref_primary_10_1016_j_ijpharm_2025_125216 crossref_primary_10_1111_cts_13159 crossref_primary_10_1080_1062936X_2016_1216010 crossref_primary_10_1016_j_pharmthera_2020_107539 crossref_primary_10_1016_j_dmpk_2019_12_002 crossref_primary_10_1124_dmd_117_079491 crossref_primary_10_1007_s00228_016_2050_0 crossref_primary_10_1002_cpt_2097 crossref_primary_10_1016_j_jddst_2019_05_006 crossref_primary_10_1016_j_ejps_2014_12_001 crossref_primary_10_1371_journal_pone_0189521 crossref_primary_10_1016_j_xphs_2017_03_027 crossref_primary_10_1007_s11695_015_1925_y crossref_primary_10_1002_jcph_703 crossref_primary_10_3389_fphar_2021_648388 crossref_primary_10_1016_j_cbi_2019_108825 crossref_primary_10_1002_bdd_2047 crossref_primary_10_1016_j_dmd_2025_100056 crossref_primary_10_1016_j_bcp_2016_03_008 crossref_primary_10_1021_acs_molpharmaceut_0c00507 crossref_primary_10_1124_dmd_116_071118 crossref_primary_10_1124_dmd_119_089656 crossref_primary_10_1124_mol_118_114314 crossref_primary_10_1093_toxsci_kfw236 crossref_primary_10_1016_j_xphs_2015_11_035 crossref_primary_10_3390_biomedicines8090340 crossref_primary_10_1002_cpt_1537 crossref_primary_10_1002_jcph_1523 crossref_primary_10_1016_j_pharmthera_2019_107397 crossref_primary_10_1080_17460441_2017_1378176 crossref_primary_10_1016_j_jpba_2015_02_043 crossref_primary_10_1124_jpet_115_230755 crossref_primary_10_3390_foods11182774 crossref_primary_10_1186_s12302_019_0212_2 crossref_primary_10_1002_bdd_2061 crossref_primary_10_1021_acs_molpharmaceut_4c00302 crossref_primary_10_1124_dmd_119_086959 crossref_primary_10_1128_AAC_00910_19 crossref_primary_10_1021_acs_molpharmaceut_7b00772 crossref_primary_10_1021_acs_molpharmaceut_4c00424 crossref_primary_10_1007_s00216_020_02445_7 crossref_primary_10_1016_j_ajcnut_2023_12_018 crossref_primary_10_1002_ncp_10615 crossref_primary_10_1021_acs_molpharmaceut_7b00076 crossref_primary_10_1021_acsmedchemlett_4c00148 crossref_primary_10_1021_acs_jcim_6b00720 crossref_primary_10_4155_fmc_15_131 crossref_primary_10_1124_dmd_121_000559 crossref_primary_10_1007_s11095_020_02834_8 crossref_primary_10_1016_j_xphs_2015_10_030 crossref_primary_10_1016_j_ejps_2023_106481 crossref_primary_10_1016_j_pharmthera_2021_107962 crossref_primary_10_1002_cpt_1112 crossref_primary_10_1021_acs_molpharmaceut_7b00627 crossref_primary_10_1089_aid_2016_0253 crossref_primary_10_1016_j_jcmgh_2016_01_006 crossref_primary_10_1124_dmd_114_061705 crossref_primary_10_1016_j_ejps_2021_105812 crossref_primary_10_1016_j_dmpk_2022_100488 crossref_primary_10_1124_dmd_121_000695 crossref_primary_10_1002_ddr_21832 crossref_primary_10_1007_s00228_018_2436_2 crossref_primary_10_1016_j_bcp_2018_06_010 crossref_primary_10_2217_pgs_2017_0104 crossref_primary_10_1016_j_cclet_2024_110529 crossref_primary_10_1016_j_xphs_2018_09_024 crossref_primary_10_1021_acs_molpharmaceut_0c00574 crossref_primary_10_1007_s11095_020_02824_w crossref_primary_10_1124_dmd_115_068684 crossref_primary_10_1002_cpt_967 crossref_primary_10_1517_17425255_2015_1055245 crossref_primary_10_1002_cpt_1328 crossref_primary_10_1080_03602532_2021_1928687 crossref_primary_10_3390_pharmaceutics13020161 crossref_primary_10_1021_acs_molpharmaceut_6b00085 crossref_primary_10_1016_j_ejmech_2016_06_039 crossref_primary_10_1021_acs_jafc_2c00065 crossref_primary_10_1016_j_ejpb_2023_08_011 crossref_primary_10_1124_dmd_118_080523 crossref_primary_10_1002_1873_3468_13982 crossref_primary_10_1038_s41573_023_00877_1 crossref_primary_10_3390_pharmaceutics13050698 crossref_primary_10_1016_j_xphs_2021_09_035 crossref_primary_10_4081_oncol_2020_448 crossref_primary_10_1021_mp500532x crossref_primary_10_1021_mp500459b crossref_primary_10_1093_toxsci_kfv102 crossref_primary_10_1016_j_addr_2016_06_004 crossref_primary_10_1021_acs_molpharmaceut_6b00754 crossref_primary_10_3389_fphar_2019_00578 crossref_primary_10_2217_pgs_2018_0101 crossref_primary_10_1016_j_ejps_2017_12_009 crossref_primary_10_1124_dmd_121_000796 crossref_primary_10_1016_j_jsbmb_2017_11_007 crossref_primary_10_1111_evj_12796 crossref_primary_10_1016_S2468_1253_20_30302_2 crossref_primary_10_3390_pharmaceutics13111789 crossref_primary_10_1021_acs_molpharmaceut_9b01121 |
Cites_doi | 10.1016/j.ejpb.2008.05.011 10.1038/clpt.1994.138 10.1038/sj.clpt.6100056 10.1007/978-3-642-14541-4_10 10.1016/S0009-9236(96)90182-4 10.1016/j.coph.2013.08.004 10.1038/clpt.2013.241 10.1007/s11095-005-2588-5 10.1021/mp3001815 10.1124/dmd.107.014902 10.1002/ibd.20030 10.2174/138920007782109788 10.1136/gut.29.8.1035 10.1016/j.ejps.2006.04.010 10.1016/j.addr.2011.07.007 10.1021/mp0600687 10.1007/s00228-011-1167-4 10.1124/dmd.111.041731 10.1038/tpj.2008.19 10.1124/pr.113.007518 10.1124/dmd.109.027367 10.1002/bdd.1810 10.1124/dmd.106.013342 10.1038/clpt.2011.4 10.1038/clpt.2013.74 10.1016/j.clpt.2003.10.004 10.1067/mcp.2002.121152 10.1111/j.1476-5381.1996.tb15612.x 10.1016/j.peptides.2012.02.009 10.5414/CPP38161 10.1345/aph.1Q414 10.1021/mp200026v 10.1023/A:1026183200740 10.1074/jbc.M103792200 10.1038/tpj.2011.60 10.1097/RLI.0b013e3182a70043 10.1016/j.ejps.2006.04.005 10.1124/dmd.113.055772 10.1111/j.1471-4159.2011.07208.x 10.1124/dmd.104.001354 10.1126/science.1135308 10.1016/j.ejps.2006.03.003 10.1111/j.1365-2036.2005.02683.x 10.1038/clpt.2010.32 10.1007/978-3-642-14541-4_4 10.1067/mcp.2000.109797 10.1016/j.bcp.2011.10.017 10.1177/0091270007312153 10.1124/mol.110.070714 10.1016/j.addr.2012.09.042 10.1016/j.clpt.2005.11.004 10.1016/j.jpba.2013.07.031 10.1016/j.clpt.2004.11.111 10.1038/nrd3028 |
ContentType | Journal Article |
Copyright | Copyright © 2014 American Chemical
Society |
Copyright_xml | – notice: Copyright © 2014 American Chemical Society |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1021/mp500330y |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1543-8392 |
EndPage | 3555 |
ExternalDocumentID | 25158075 10_1021_mp500330y i73030108 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 123 4.4 53G 55A 7~N AABXI ABMVS ABUCX ACGFS ACS AEESW AENEX AFEFF ALMA_UNASSIGNED_HOLDINGS AQSVZ CS3 DU5 EBS ED ED~ EJD F5P GNL H~9 IH9 JG JG~ LG6 P2P RNS ROL UI2 VF5 VG9 W1F X --- -~X 5VS AAYXX ABBLG ABJNI ABLBI ABQRX ADHLV AHGAQ BAANH CITATION CUPRZ GGK CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-a381t-3dce3536623225f874c722d89b81866eb324e9ed8d732ff30b80a79a8c898e823 |
IEDL.DBID | ACS |
ISSN | 1543-8384 1543-8392 |
IngestDate | Fri Jul 11 02:52:51 EDT 2025 Thu Jan 02 22:13:49 EST 2025 Thu Apr 24 23:04:38 EDT 2025 Tue Jul 01 04:33:35 EDT 2025 Thu Aug 27 13:42:06 EDT 2020 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | drug transporters intestine protein abundance human gene expression |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-a381t-3dce3536623225f874c722d89b81866eb324e9ed8d732ff30b80a79a8c898e823 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 25158075 |
PQID | 1609098254 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1609098254 pubmed_primary_25158075 crossref_citationtrail_10_1021_mp500330y crossref_primary_10_1021_mp500330y acs_journals_10_1021_mp500330y |
ProviderPackageCode | JG~ 55A AABXI GNL VF5 7~N VG9 W1F ACS AEESW AFEFF ABMVS ABUCX IH9 AQSVZ ED~ UI2 CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2014-10-06 |
PublicationDateYYYYMMDD | 2014-10-06 |
PublicationDate_xml | – month: 10 year: 2014 text: 2014-10-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Molecular pharmaceutics |
PublicationTitleAlternate | Mol. Pharmaceutics |
PublicationYear | 2014 |
Publisher | American Chemical Society |
Publisher_xml | – name: American Chemical Society |
References | Glaeser H. (ref50/cit50) 2007; 81 Weitschies W. (ref42/cit42) 2008; 70 Haenisch S. (ref39/cit39) 2011; 80 Uchida Y. (ref51/cit51) 2011; 117 Tubic M. (ref18/cit18) 2006; 29 Guo X. (ref43/cit43) 2012; 34 Schiller C. (ref5/cit5) 2005; 22 Chen L. (ref38/cit38) 2013; 13 Schwarz U. I. (ref27/cit27) 2000; 38 Dawson P. A. (ref30/cit30) 2011; 201 Barr W. H. (ref13/cit13) 1994; 56 Oswald S. (ref31/cit31) 2006; 79 Evans D. F. (ref44/cit44) 1988; 29 Rebello S. (ref53/cit53) 2012; 68 Zimmermann C. (ref12/cit12) 2005; 33 Groer C. (ref24/cit24) 2013; 85 Konig J. (ref3/cit3) 2013; 65 Keppler D. (ref46/cit46) 2014; 42 Mouly S. (ref7/cit7) 2003; 20 Cortvriendt W. R. (ref41/cit41) 1987; 37 Estudante M. (ref1/cit1) 2013; 65 Tirona R. G. (ref35/cit35) 2001; 276 Schwarz U. I. (ref54/cit54) 2005; 77 Naddaf F. (ref49/cit49) 2010; 70 Tamai I. (ref55/cit55) 2012; 64 Hillgren K. M. (ref23/cit23) 2013; 94 Tirona R. G. (ref32/cit32) 2011; 201 Englund G. (ref19/cit19) 2007; 13 Misaka S. (ref56/cit56) 2014; 95 Ming X. (ref48/cit48) 2011; 8 Jia J. (ref45/cit45) 2014; 49 Giacomini K. M. (ref22/cit22) 2010; 9 Huang S. M. (ref4/cit4) 2008; 48 Weitschies W. (ref17/cit17) 2005; 22 Tucker T. G. (ref26/cit26) 2012; 83 Westphal K. (ref34/cit34) 2000; 68 Dresser G. K. (ref52/cit52) 2002; 71 Fisher M. B. (ref2/cit2) 2007; 8 Fricker G. (ref14/cit14) 1996; 118 Skottheim I. B. (ref16/cit16) 2010; 87 Engel A. (ref25/cit25) 2012; 9 Hilgendorf C. (ref9/cit9) 2007; 35 Seithel A. (ref11/cit11) 2006; 28 Edwards A. (ref28/cit28) 2012; 46 Chen Y. (ref36/cit36) 2009; 9 Harwood M. D. (ref21/cit21) 2013; 34 Brandsch M. (ref40/cit40) 2013; 13 Oswald S. (ref29/cit29) 2011; 89 Englund G. (ref8/cit8) 2006; 29 Wojtal K. A. (ref20/cit20) 2009; 37 Kimchi-Sarfaty C. (ref37/cit37) 2007; 315 Berggren S. (ref6/cit6) 2007; 4 de Waart D. R. (ref47/cit47) 2012; 40 Giessmann T. (ref33/cit33) 2004; 75 Meier Y. (ref10/cit10) 2007; 35 Gramatte T. (ref15/cit15) 1996; 59 |
References_xml | – volume: 70 start-page: 641 issue: 2 year: 2008 ident: ref42/cit42 publication-title: Eur. J. Pharm. Biopharm. doi: 10.1016/j.ejpb.2008.05.011 – volume: 56 start-page: 279 issue: 3 year: 1994 ident: ref13/cit13 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.1994.138 – volume: 81 start-page: 362 issue: 3 year: 2007 ident: ref50/cit50 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/sj.clpt.6100056 – volume: 201 start-page: 373 year: 2011 ident: ref32/cit32 publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-642-14541-4_10 – volume: 59 start-page: 541 issue: 5 year: 1996 ident: ref15/cit15 publication-title: Clin. Pharmacol. Ther. doi: 10.1016/S0009-9236(96)90182-4 – volume: 13 start-page: 881 issue: 6 year: 2013 ident: ref40/cit40 publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2013.08.004 – volume: 95 start-page: 432 issue: 4 year: 2014 ident: ref56/cit56 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2013.241 – volume: 22 start-page: 728 issue: 5 year: 2005 ident: ref17/cit17 publication-title: Pharm. Res. doi: 10.1007/s11095-005-2588-5 – volume: 9 start-page: 2577 issue: 9 year: 2012 ident: ref25/cit25 publication-title: Mol. Pharmaceutics doi: 10.1021/mp3001815 – volume: 35 start-page: 1333 issue: 8 year: 2007 ident: ref9/cit9 publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.107.014902 – volume: 37 start-page: 977 issue: 8 year: 1987 ident: ref41/cit41 publication-title: Arzneimittelforschung – volume: 13 start-page: 291 issue: 3 year: 2007 ident: ref19/cit19 publication-title: Inflammatory Bowel Dis. doi: 10.1002/ibd.20030 – volume: 8 start-page: 694 issue: 7 year: 2007 ident: ref2/cit2 publication-title: Curr. Drug Metab. doi: 10.2174/138920007782109788 – volume: 29 start-page: 1035 issue: 8 year: 1988 ident: ref44/cit44 publication-title: Gut doi: 10.1136/gut.29.8.1035 – volume: 29 start-page: 269 issue: 3 year: 2006 ident: ref8/cit8 publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2006.04.010 – volume: 64 start-page: 508 issue: 6 year: 2012 ident: ref55/cit55 publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2011.07.007 – volume: 4 start-page: 252 issue: 2 year: 2007 ident: ref6/cit6 publication-title: Mol. Pharmaceutics doi: 10.1021/mp0600687 – volume: 68 start-page: 697 issue: 5 year: 2012 ident: ref53/cit53 publication-title: Eur. J. Clin. Pharmacol. doi: 10.1007/s00228-011-1167-4 – volume: 40 start-page: 515 issue: 3 year: 2012 ident: ref47/cit47 publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.111.041731 – volume: 9 start-page: 127 issue: 2 year: 2009 ident: ref36/cit36 publication-title: Pharmacogenomics J. doi: 10.1038/tpj.2008.19 – volume: 65 start-page: 944 issue: 3 year: 2013 ident: ref3/cit3 publication-title: Pharmacol. Rev. doi: 10.1124/pr.113.007518 – volume: 37 start-page: 1871 issue: 9 year: 2009 ident: ref20/cit20 publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.109.027367 – volume: 34 start-page: 2 issue: 1 year: 2013 ident: ref21/cit21 publication-title: Biopharm. Drug Dispos. doi: 10.1002/bdd.1810 – volume: 35 start-page: 590 issue: 4 year: 2007 ident: ref10/cit10 publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.106.013342 – volume: 89 start-page: S29 year: 2011 ident: ref29/cit29 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2011.4 – volume: 94 start-page: 52 issue: 1 year: 2013 ident: ref23/cit23 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2013.74 – volume: 75 start-page: 213 issue: 3 year: 2004 ident: ref33/cit33 publication-title: Clin. Pharmacol. Ther. doi: 10.1016/j.clpt.2003.10.004 – volume: 71 start-page: 11 issue: 1 year: 2002 ident: ref52/cit52 publication-title: Clin. Pharmacol. Ther. doi: 10.1067/mcp.2002.121152 – volume: 118 start-page: 1841 issue: 7 year: 1996 ident: ref14/cit14 publication-title: Br. J. Pharmacol. doi: 10.1111/j.1476-5381.1996.tb15612.x – volume: 34 start-page: 395 issue: 2 year: 2012 ident: ref43/cit43 publication-title: Peptides doi: 10.1016/j.peptides.2012.02.009 – volume: 70 start-page: 23 year: 2010 ident: ref49/cit49 publication-title: Br. J. Clin. Pharmacol. – volume: 38 start-page: 161 issue: 4 year: 2000 ident: ref27/cit27 publication-title: Int. J. Clin. Pharmacol. Ther. doi: 10.5414/CPP38161 – volume: 46 start-page: 130 issue: 1 year: 2012 ident: ref28/cit28 publication-title: Ann. Pharmacother. doi: 10.1345/aph.1Q414 – volume: 8 start-page: 1677 issue: 5 year: 2011 ident: ref48/cit48 publication-title: Mol. Pharmaceutics doi: 10.1021/mp200026v – volume: 20 start-page: 1595 issue: 10 year: 2003 ident: ref7/cit7 publication-title: Pharm. Res. doi: 10.1023/A:1026183200740 – volume: 276 start-page: 35669 issue: 38 year: 2001 ident: ref35/cit35 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M103792200 – volume: 13 start-page: 110 issue: 2 year: 2013 ident: ref38/cit38 publication-title: Pharmacogenomics J. doi: 10.1038/tpj.2011.60 – volume: 49 start-page: 78 issue: 2 year: 2014 ident: ref45/cit45 publication-title: Invest. Radiol. doi: 10.1097/RLI.0b013e3182a70043 – volume: 29 start-page: 231 issue: 3 year: 2006 ident: ref18/cit18 publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2006.04.005 – volume: 42 start-page: 561 year: 2014 ident: ref46/cit46 publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.113.055772 – volume: 117 start-page: 333 issue: 2 year: 2011 ident: ref51/cit51 publication-title: J. Neurochem. doi: 10.1111/j.1471-4159.2011.07208.x – volume: 33 start-page: 219 issue: 2 year: 2005 ident: ref12/cit12 publication-title: Drug Metab. Dispos. doi: 10.1124/dmd.104.001354 – volume: 315 start-page: 525 issue: 5811 year: 2007 ident: ref37/cit37 publication-title: Science doi: 10.1126/science.1135308 – volume: 28 start-page: 291 issue: 4 year: 2006 ident: ref11/cit11 publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2006.03.003 – volume: 22 start-page: 971 issue: 10 year: 2005 ident: ref5/cit5 publication-title: Aliment. Pharmacol. Ther. doi: 10.1111/j.1365-2036.2005.02683.x – volume: 87 start-page: 699 issue: 6 year: 2010 ident: ref16/cit16 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2010.32 – volume: 201 start-page: 169 year: 2011 ident: ref30/cit30 publication-title: Handb. Exp. Pharmacol. doi: 10.1007/978-3-642-14541-4_4 – volume: 68 start-page: 345 issue: 4 year: 2000 ident: ref34/cit34 publication-title: Clin. Pharmacol. Ther. doi: 10.1067/mcp.2000.109797 – volume: 83 start-page: 279 issue: 2 year: 2012 ident: ref26/cit26 publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2011.10.017 – volume: 48 start-page: 662 issue: 6 year: 2008 ident: ref4/cit4 publication-title: J. Clin. Pharmacol. doi: 10.1177/0091270007312153 – volume: 80 start-page: 314 issue: 2 year: 2011 ident: ref39/cit39 publication-title: Mol. Pharmacol. doi: 10.1124/mol.110.070714 – volume: 65 start-page: 1340 issue: 10 year: 2013 ident: ref1/cit1 publication-title: Adv. Drug Delivery Rev. doi: 10.1016/j.addr.2012.09.042 – volume: 79 start-page: 206 issue: 3 year: 2006 ident: ref31/cit31 publication-title: Clin. Pharmacol. Ther. doi: 10.1016/j.clpt.2005.11.004 – volume: 85 start-page: 253 year: 2013 ident: ref24/cit24 publication-title: J. Pharm. Biomed. Anal. doi: 10.1016/j.jpba.2013.07.031 – volume: 77 start-page: 291 issue: 4 year: 2005 ident: ref54/cit54 publication-title: Clin. Pharmacol. Ther. doi: 10.1016/j.clpt.2004.11.111 – volume: 9 start-page: 215 issue: 3 year: 2010 ident: ref22/cit22 publication-title: Nat. Rev. Drug Discovery doi: 10.1038/nrd3028 |
SSID | ssj0024523 |
Score | 2.520401 |
Snippet | Intestinal transporters are crucial determinants in the oral absorption of many drugs. We therefore studied the mRNA expression (N = 33) and absolute protein... |
SourceID | proquest pubmed crossref acs |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 3547 |
SubjectTerms | Adult Colon - metabolism Duodenum - metabolism Female Humans Ileum - metabolism In Vitro Techniques Intestinal Absorption Intestine, Small - metabolism Intestines - metabolism Jejunum - metabolism Male Membrane Transport Proteins - genetics Membrane Transport Proteins - metabolism Middle Aged Multidrug Resistance-Associated Proteins - genetics Multidrug Resistance-Associated Proteins - metabolism Organic Cation Transport Proteins - genetics Organic Cation Transport Proteins - metabolism RNA, Messenger - metabolism Symporters - genetics Symporters - metabolism Young Adult |
Title | Protein Abundance of Clinically Relevant Multidrug Transporters along the Entire Length of the Human Intestine |
URI | http://dx.doi.org/10.1021/mp500330y https://www.ncbi.nlm.nih.gov/pubmed/25158075 https://www.proquest.com/docview/1609098254 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dT9swED_x8cILDAas26i8gSoeSEntfNiPVSmqEJsqKBJvkZ3Y3bTiojZ96P76nZO0BfGx18h2rNyd73c53-8AThz5seCRQUvLYg89lPGUL5TnB6lSRrSM1K5Q-MfPqHcXXN2H92tw_EYGn7bOHx5D13DMn6_DJo147CKsdud2RagXFj3cEAowjzMeLOiDnk51riedPnc9b-DJwq9c7sDFojqnvE7ypznLVTP9-5Ks8b0tf4DtCleSdqkIu7Cm7R40-iUx9fyMDFZ1VtMz0iD9FWX1_CPYvqNr-G1JW7nKEFQEMjak4gwdjebkxpWhoxBIUbCbTWZDsqJFn0yJHI3tkCCYJF2b4ylKrrUd5r_cKu5hkSog7u8jnihW78PdZXfQ6XlVJwZPokfPPZalmoUsQqyE9m94HKQxpRkXqiDMw4CcBlrojGcxo8YwX3FfxkLylAuuOWUHsGHHVn8CEhmJiAzjvJZvApwkRUR5KoSJJWKPgNWgjqJKKkuaJkWSnLaS5TetwelCikla8Zi7dhqj14Z-Xw59LMk7Xhv0baEKCZqWy5dIq8czfHXkC1-4ELoGh6WOLJdBWBg6HufP_9vuF9hCjBUU9_-ir7CRT2b6CHFMruqFHv8DfqTsHA |
linkProvider | American Chemical Society |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfYeNhexmCMFVgxE6p4aEoa58N-rKZWBdqqGq3Ut8hO7IIobtWkD-Wv5-ykzYaKxmvkj5N99v0u5_sdQh8M-TGjoYKTlkYOWCjlCJcJx_UTIRRrKy5NovBwFPan_pdZMCtpckwuDAiRwUiZDeJX7ALtT79Wgak75m6P0FMAIZ5xtDq33ypevcCWcgNEQBxKqL9jEbrf1VigJHtogf4BK6156T0r6hRZweyrkp-tTS5aye-_OBv_T_JzdFaiTNwp1OI5eiL1C9QYFzTV2yaeVFlXWRM38LgisN5eID025A0_NO4IkycCaoGXCpcMoovFFt-ZpHTYEmzTd9P1Zo4rkvR1hvliqecYoCXu6hzuVDyQep5_N6OYjzZwgM2_SLhftHyJpr3u5LbvlHUZHA72PXdImkgSkBCQE9wGikZ-EnleSpmw9Hngnnu-ZDKlaUQ8pYgrqMsjxmlCGZXUI5foWC-1vEI4VBzwGXh9bVf50Imz0KMJYyrigER8UkN1WNK4PFdZbEPmXjver2kNfdxtZpyUrOamuMbiUNObfdNVQeVxqNH7nUbEcNBM9IRrudzA1KHLXGYc6hp6VajKfhgAiYFhdX79mLjv0El_MhzEg8-jr2_QKaAv374MDN-i43y9kdeAcHJRt6r9B2IU9H0 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwED_BkBAvGwwY3WAYhCYelpHG-bAfq7FqX4wKNmlvkZ3Y3bTOrZr0ofvrd-emLaAheI0c52Tf-X6X8_0O4BORH0uRWrS0MgvQQ9lAh1IHYVxobWXbKkOFwt_O0sOL-PgyuWwCRaqFQSEqnKnySXyy6lFpG4aB9pfbUUK9x8LpY3hC6ToKtjr7P5fceolv54aogAeCi3jOJPTrq-SFiup3L_QXaOldTHcNvi-E8zdLbvYmtd4r7v7gbfx_6Z_DaoM2WWemHi_gkXHrsNOb0VVPd9n5svqq2mU7rLcksp6-BNcjEodrxzqa6kVQPdjQsoZJdDCYsh9UnI5bw3wZbzme9NmSLH1cMTUYuj5DiMkOXI1nKzs1rl9f0Sz00CcQGP2TxHPGmVdw0T043z8Mmv4MgUI_Xwe8LAxPeIoICk8FK7K4yKKoFFJ7Gj0M06PYSFOKMuORtTzUIlSZVKIQUhgR8dew4obOvAGWWoU4DaO_dmhjfEnJNBKFlDZTiEhi3oJtXNa8sa8q96nzqJ0v1rQFn-cbmhcNuzk12Rg8NPTjYuhoRunx0KAPc63I0eAoi6KcGU7w02koQ0mBdQs2ZuqymAbBYkLszpv_Evc9PO197eanR2cnW_AMQVjsLwimb2GlHk_MOwQ6td722n0PZY33AA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Protein+abundance+of+clinically+relevant+multidrug+transporters+along+the+entire+length+of+the+human+intestine&rft.jtitle=Molecular+pharmaceutics&rft.au=Drozdzik%2C+Marek&rft.au=Gr%C3%B6er%2C+Christian&rft.au=Penski%2C+Jette&rft.au=Lapczuk%2C+Joanna&rft.date=2014-10-06&rft.issn=1543-8392&rft.eissn=1543-8392&rft.volume=11&rft.issue=10&rft.spage=3547&rft_id=info:doi/10.1021%2Fmp500330y&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1543-8384&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1543-8384&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1543-8384&client=summon |